New England Journal of Medicine Issues Research Articles in Oct. 31, 2024 Edition
November 02, 2024
November 02, 2024
WALTHAM, Massachusetts, Nov. 2 -- The New England Journal of Medicine, a peer-reviewed medical journal from the Massachusetts Medical Society that says it delivers research and interactive clinical content to physicians, educators and the global medical community, published research articles on the following topics in its Oct. 31, 2024, edition (Vol. 391, No. 17):
* Isatuximab, Bortezomib, Lenalidomide, and Dexamethasone for Multiple Myeloma
* Once-Weekly Semaglutide in . . .
* Isatuximab, Bortezomib, Lenalidomide, and Dexamethasone for Multiple Myeloma
* Once-Weekly Semaglutide in . . .